Planned Home Births Associated with Tripling of Neonatal Mortality Rate Compared to Planned Hospital Births

According to New Study Published in the American Journal of Obstetrics & Gynecology

Philadelphia, PA, About 1 in 200 women in the US delivers her baby at home, with approximately 75% of these low-risk, single-baby births planned in advance as home deliveries. In a study published online today by the American Journal of Obstetrics & Gynecology (AJOG), researchers from Maine Medical Center, Portland, Maine, analyzed the results of multiple studies from around the world. They report that less medical intervention, characteristic of planned home births, is associated with a tripling of the neonatal mortality rate compared to planned hospital deliveries. Planned home births were characterized by a greater proportion of deaths attributed to respiratory distress and failed resuscitation.

“Our findings raise the question of a link between the increased neonatal mortality among planned home births and the decreased obstetric intervention in this group,” according to lead investigator Joseph R. Wax, MD, Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Maine Medical Center. “Women choosing home birth, particularly low-risk individuals who had given birth previously, are in large part successful in achieving their goal of delivering with less morbidity and medical intervention than experienced during hospital-based childbirth. Of significant concern, these apparent benefits are associated with a doubling of the neonatal mortality rate overall and a near tripling among infants born without congenital defects (nonanomalous). …These findings echo concerns raised in a recent large US cohort study in which home births experienced significantly more 5-minute Apgar scores less than 7 as compared to low-risk term hospital births, suggesting an increased need for resuscitation among home births. Therefore, the personnel, training, and equipment available for neonatal resuscitation represent other possible contributors to the excessive neonatal mortality rate among planned home births.”

Investigators conducted a rigorous metaanalysis through which the peer-reviewed medical literature was searched for studies that contained information about home and hospital deliveries, including morbidity and mortality data for both mother and child. They extracted data for a total of 342,056 planned home and 207,551 planned hospital deliveries. The results are striking as women planning home births were of similar and often lower obstetric risk than those planning hospital births.

In contrast to neonatal mortality rates, investigators observed that perinatal mortality rates for planned home and hospital births were similar overall, as well as just among nonanomalous offspring.

Mothers in planned home births experienced significantly fewer medical interventions including epidural analgesia, electronic fetal heart rate monitoring, episiotomy, and operative vaginal and cesarean deliveries. Likewise, women intending home deliveries had fewer infections, perineal and vaginal lacerations, hemorrhages, and retained placentas. Data also showed that planned home births are characterized by less frequent premature and low birthweight infants.

AJOG Editors-in- Chief Thomas J. Garite, MD, and Moon H. Kim, MD, commented that “The report by Wax et al supports the safety of planned home birth for the mother, but raises serious concerns about increased risks of home birth for the newborn infant. This topic deserves more attention from public health officials at state and national levels.”

The article is “Maternal and newborn outcomes in planned home birth vs planned hospital births: a metaanalysis” by Joseph R. Wax, MD; F. Lee Lucas, PhD; Maryanne Lamont, MLS; Michael G. Pinette, MD; Angelina Cartin; and Jacquelyn Blackstone, DO. It will appear in the American Journal of Obstetrics & Gynecology, Volume 203, Issue 3 (September 2010) published by Elsevier. DOI: 10.1016/j.ajog.2010.05.028

# # #

Full text of the article is available to journalists upon request. Contact Andrea Boccelli at 215-239-3713 or ajogmedia@elsevier.com to obtain a copy. Journalists wishing to schedule interviews with the authors should contact John Lamb, Communications Manager, Maine Medical Center, at 207-662-4405, 207-662-4094 (fax) or via email: lambj3@mmc.org.

About the American Journal of Obstetrics & Gynecology
The American Journal of Obstetrics & Gynecology (www.AJOG.org), known as “The Gray Journal,” presents coverage of the entire spectrum of the field, from the newest diagnostic procedures to leading-edge research. The Journal provides comprehensive coverage of the specialty, including maternal-fetal medicine, reproductive endocrinology/infertility, and gynecologic oncology. It also publishes the annual meeting papers of several of its 7 sponsoring societies, including the Society for Maternal-Fetal Medicine and the Society of Gynecologic Surgeons.

The American Journal of Obstetrics & Gynecology’s 2009 Impact Factor is 3.278. It is ranked 7th out of 70 and continues to be ranked #1 in citations in the Obstetrics & Gynecology category, according to the latest Journal Citation Reports® 2010, published by Thomson Reuters. The Journal’s standard of excellence and continued success can be attributed to the strong leadership of the Editors-in-Chief, Thomas J. Garite, MD, and Moon H. Kim, MD, and their outstanding nationally and internationally recognized editorial board and reviewers. The journal has also been recognized as one of the 100 most influential journals in Biology & Medicine over the last 100 years, as determined by the BioMedical & Life Sciences Division of the Special Libraries Association (2009).

About Elsevier Elsevier is a world-leading publisher of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including The Lancet and Cell, and close to 20,000 book titles, including major reference works from Mosby and Saunders. Elsevier’s online solutions include ScienceDirect, Scopus, Reaxys, MD Consult and Nursing Consult, which enhance the productivity of science and health professionals, and the SciVal suite and MEDai’s Pinpoint Review, which help research and health care institutions deliver better outcomes more cost-effectively.

A global business headquartered in Amsterdam, Elsevier employs 7,000 people worldwide. The company is part of Reed Elsevier Group PLC, a world-leading publisher and information provider, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange)